Merck's (MRK) New Pneumococcal Jab Capvaxive Gets CDC Panel Vote

Yahoo FinanceJun 28 19:28

Annovis Bio Files Provisional Patent for New Manufacturing Process of Crystalline Form of Buntanetap

Thu, 27 Jun 2024MALVERN, Pa., June 27, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transform

Annovis BioJun 27 12:00

Express News | Annovis Bio Inc: Files Patent for New Composition of Matter for Buntanetap

BreakingsJun 26 20:01

Annovis Bio Files Patent for New Composition of Matter for Buntanetap

Wed, 26 Jun 2024MALVERN, Pa., June 26, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transform

Annovis BioJun 26 12:00

Annovis Bio Inc. (NYSE: ANVS) Schedules Investor Webcast to Discuss Parkinson's Disease Data

Tue, 25 Jun 2024MALVERN, Pa., June 25, 2024 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage clinical drug platform company pioneering transform

Annovis BioJun 25 12:00

Annovis Bio Highlights New Alzheimer's Data at the Alzheimer's Association International Conference 2024

Tue, 18 Jun 2024MALVERN, Pa., June 18, 2024 (GLOBE NEWSWIRE) -- via IBN -- Annovis Bio Inc. (NYSE: ANVS) ("Annovis" or the "Company"), a late-stage drug platform company developing novel therapies f

Annovis BioJun 18 12:00